Realtime | Geld | Brief | Zeit |
---|---|---|---|
11,630 | 11,690 | 01.04. | |
11,635 | 11,805 | 01.04. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
---|---|---|---|---|
26.03. | Dynavax Technologies-Präsident verkauft Aktien im Wert von 140.000 US-Dollar | 5 | Investing.com Deutsch | |
20.03. | Dynavax Technologies-Präsident verkauft Aktien im Wert von 190.391 US-Dollar | 5 | Investing.com Deutsch | |
13.03. | DYNAVAX TECHNOLOGIES CORP - 8-K, Current Report | 3 | SEC Filings | |
06.03. | Dynavax to execute debt refinancing | 6 | Seeking Alpha | |
06.03. | DYNAVAX TECHNOLOGIES CORP - 8-K, Current Report | 1 | SEC Filings | |
21.02. | Dynavax Technologies (NASDAQ:DVAX) Announces Earnings Results | 14 | MarketBeat | |
21.02. | Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings) | 2 | Benzinga.com | |
21.02. | H.C. Wainwright maintains Buy on Dynavax stock with $31 target | 6 | Investing.com | |
DYNAVAX Aktie jetzt für 0€ handeln | ||||
21.02. | JMP raises Dynavax stock target to $33, maintains rating | 5 | Investing.com | |
21.02. | Dynavax projects HEPLISAV-B revenue of $305M-$325M for 2025 amid expanding hepatitis B market | 6 | Seeking Alpha | |
20.02. | Dynavax GAAP EPS of $0.05 beats by $0.01, revenue of $72.03M misses by $0.67M | 4 | Seeking Alpha | |
20.02. | Dynavax Technologies: Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance | 149 | PR Newswire | |
20.02. | DYNAVAX TECHNOLOGIES CORP - 10-K, Annual Report | - | SEC Filings | |
20.02. | DYNAVAX TECHNOLOGIES CORP - 8-K, Current Report | 2 | SEC Filings | |
20.02. | Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors | 4 | Reuters | |
19.02. | Dynavax defends strategy amid board nomination dispute | 3 | Investing.com | |
19.02. | Dynavax verteidigt Strategie | 5 | Investing.com Deutsch | |
19.02. | Deep Track nominates candidates for Dynavax's board, launching proxy fight to end company's 'empire-building' strategy | 2 | FierceBiotech | |
19.02. | Dynavax Technologies climbs as investor begins proxy fight | 2 | Seeking Alpha | |
11.02. | Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty | 7 | Benzinga.com |